The Federal Circuit Court holds exclusive authority over all U.S. pharmaceutical patent cases, shaping when generics enter the market, how patents are enforced, and the cost of medicines. Its rulings on ANDA litigation, dosing patents, and jurisdiction have transformed drug development.